Top 50 Medical Startup Investors in Asia in April 2025

Investor	Medical Asia investments
HSG	34
BioVenture	31
Med-Fine Capital	25
Qiming Venture Partners	24
Legend Capital	22
Frees Fund	18
Cowin Venture	18
Prox Ventures	17
Mitsubishi UFJ Capital	17
Puhua Capital	17
Marathon Venture Partners	17
Matrix Partners China	16
Northern Light Venture Capital	15
Share Capital	15
Lilly Asia Ventures	14
Legend Star	14
Jan Hammer	14
IDG Capital	14
Dalton Venture	13
Highlight Capital	13
UTEC - The University of Tokyo Edge Capital Partners	12
BioTrack Capital	12
Keio Innovation Initiative	11
SMBC Venture Capital	11
Cowin Capital	11
Sherpa Healthcare Partners	11
Goldport Capital	11
ANRI	11
Lenovo Capital and Incubator Group (LCIG)	10
CDH Investments	10
Cenova	10
Gaorong Capital	9
Huagai Capital	9
CD Capital	9
Taiyu Investment	9
UntroD Capital	9
Nissay Capital	9
Hillhouse Investment	9
Trustbridge Partners	9
Sunland Fund	9
Tiantu Capital	8
LYFE Capital	8
Insight Capital	8
Co-Stone Venture Capital	8
Shenzhen Capital Group	8
Long Hill Capital	8
SBCVC	8
Taiyu Investment	8
BIOCHING CAPITAL	8
Oriental Fortune Capital	8

We help founders build enduring companies.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Manus AI — Manus is a general AI agent that bridges thoughts and actions by excelling in various tasks such as research, data analysis, education, and productivity, offering personalized solutions across different domains to help users achieve their goals efficiently.
RedotPay — RedotPay is a leading crypto fintech bridging Web3 and traditional finance through innovative, cost-efficient blockchain solutions. Our intuitive crypto payment products enable millions of users globally to easily spend and send digital assets. We foster financial inclusion for the unbanked and serve crypto enthusiasts, advancing global adoption offast, accessible crypto payments.
Danking Pharmaceuticals — Danking Medicine is an innovation-driven drug developer.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Taiwan

Portfolio highlights

AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
Hengyu Medical — Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.
MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
China, United States

Portfolio highlights

ZD Medical — ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
BV Laser — BV Laser is a manufacturer of medical beauty equipment.
Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
Xinzeyuan Medical — Xinzeyuan Medical is a manufacturer of key precision components and medical endoscope consumables.
Iongen Therepeutics — Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

Picea Motion — Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.
AiCheng Technology — Suzhou Aicheng Technology is an organization that seamlessly integrates research and development (R&D) with production processes.
TBSTest Technology — Yuexin Technology is a semiconductor test equipment developer specializing in R&D, production and sales of ultra-large-scale integrated circuit test equipment (ATE). Its main product is SOC test equipment, which is mainly for enterprise users of integrated circuit design, production, packaging and testing. Integrated circuit test equipment andsolutions.

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Investment focus

Artificial Intelligence, Medical, Biotechnology
Series A, Seed, Angel
China, United States, Singapore

Portfolio highlights

XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
Dezao Technology — Dezao Technology is an e-commerce transaction provider, mostly involved in the sales of electronic products, mobile phones, and mobile phone accessories.
Yuanluo Technology — Yuanluo Technology is committed to providing innovative robotic solutions across multiple industries, including health, logistics, and service sectors.

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

Investment focus

Health Care, Biotechnology, Medical
Series A, Angel, Series B
China, United States, Canada

Portfolio highlights

Fine Vision — Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition.
Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
Guanchen Biotechnology — Guanchen Biotechnology is a developer of innovative cosmetic ingredients.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Seed, Funding Round, Series A
China, United States, United Kingdom

Portfolio highlights

Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.
Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Investment focus

Information Technology, Software, Health Care
Funding Round, Series A, Series B
Japan, United States, China

Portfolio highlights

Ababa — Ababa provides recruitment and employment solutions.
Emium — Emium creates an infrastructure that will be a driving force in dental care and dental technology.
RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Investment focus

Health Care, Medical, Manufacturing
Series A, Series B, Seed
China, United Kingdom, United States

Portfolio highlights

Teemo — Teemo is an industry-leading provider of intelligent skateboard chassis and low- and medium-speed unmanned driving solutions.
Aptech — Aptech is a creative firm focused on cutting-edge biotechnology, with a strong scientific research foundation from first-rate domestic scientific research institutions and substantial backing.
Silicon Mobile Technology — Silicon Mobile Technology is an AI infrastructure company that specilaizes in large models inference and deployment system to reduce the cost in the AIGC and LLM industries.

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Angel
China, United States, Hong Kong

Portfolio highlights

Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
Kangai Medical — Kangai Medical specialises on clinical nutrition and rehabilitation
Femtosecond Technology — Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization.

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

LeXiang Intelligence — LeXiang Intelligence is a robotics company that specializes in the development of intelligent consumer-grade robots.
Zhongcheng Technology — Zhongcheng Technology is a centralized lubrication system developer that focuses on the research and development, manufacturing, sales, and technical services of centralized lubrication systems.
Titanium Robotics Technology — Titanium Robotics Technology specializing in the development and production of advanced robot hardware and solutions. It focuses on customized services, R&D, and production of robot hardware, aiming to create high-performance, industry standard products, develops lightweight, collaborative robots, humanoid robots, and exoskeletons, leading thesupply chain towards lightweight, miniaturization, and ease of use.

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, South Korea

Portfolio highlights

VOC AI — VOC AI offers AI tools for ecommerce insights and customer service solutions.
AscentStream — AscentStream is a software development company that provides cloud messaging software and stream processing solutions.
Shengrun New Materials — Shengrun New Materials is an aerogel material and system solution service provider integrating advanced material process research and development, product application development, advanced production line design, and mature system solutions.

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Colombia

Portfolio highlights

Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Fine Vision — Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition.
Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Angel
China, United States, France

Portfolio highlights

BlueSky Aviation — BlueSky Aviation focuses on the research and development of electric vertical take-off and landing aircraft.
Primus Labs — Primus connects Web2 data to Web3, offering verified information to AI models while ensuring user privacy.
Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.

Jan joined Index in 2010, and is a London-based partner, focusing on fintech and information/data services across all stages of growth.He is one of Index Ventures’ leading fintech investors, working with the founders of Adyen, Credit Benchmark, Robinhood and TransferWise. In all, Index has backed more than two dozen fintech companies, withmore than $400 million. Jan has also led Index investments and is on the boards of Beamery, Collibra, SafetyCulture and Silverfin.Before he joined Index, Jan was at General Atlantic in London, where he worked on investments in Kaspersky Lab, Northgate Information Solutions and Torex Retail. He also worked in the M&A, TMT and Capital Markets divisions at Morgan Stanley. Jan is a graduate of Oxford University, and holds an MBA with Distinction from INSEAD.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China, United States, United Kingdom

Portfolio highlights

MacroLux — MacroLux operates as a medical technology company focusing on endoscopic interventional business. MacroLux develops endoscopic interventional therapy solutions and promote them to the majority of medical customers.
Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.

IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.

Investment focus

Software, Internet, E-Commerce
Series A, Series B, Series C
China, United States, India

Portfolio highlights

ChainOpera AI — ChainOpera AI - The Blockchain and Protocol for Co-owning and Co-creating Decentralized AI Apps and Agents for Humanity, Backed by Federated AI OS and Platform
Xinyanyi Code — Xinyanyi Code is an artificial intelligence programming application service provider that focuses on AI Coding and benchmarks the American intelligent code generation product Cursor.
Yin Gong Technology — Yin Gong Technology develops energy storage technology. It is an innovative battery technology developer in the green technology field.

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Investment focus

Health Care, Medical, Medical Device
Seed, Series A, Series B
India, China, Canada

Portfolio highlights

LegitQuest — An online legal research platform with Indian case laws. Research on Indian Cases, Judgments & Acts with AI enabled, User friendly product features.
Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Portugal

Portfolio highlights

ENGINEAI — ENGINEAI is committed to advancing the commercialization of humanoid robot technology worldwide.
Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Funding Round
Japan, United States, Singapore

Portfolio highlights

Issin — Issin manufactures bath mats that can measure weight and automatically record daily weight changes on your smartphone.
RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
Eureka Robotics — Eureka Robotics develop robotics technologies and products to automate the mundane, so that humans can focus on the creative.

BioTrack Capital is a China-based investment firm.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Singapore

Portfolio highlights

Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
Rona Therapeutics — Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines.
Moyang Biotechnology — Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector.

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

Investment focus

Health Care, Medical, Biotechnology
Funding Round, Series A, Seed
Japan

Portfolio highlights

JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
Aeterlink — Aeterlink is a wireless device maker and developer. They applied their technology to fields such as FA, robots, smart houses, and medicine and developed practical level technologies such as elemental technology that can wirelessly supply power.
Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

Investment focus

Information Technology, Health Care, Software
Funding Round, Series B, Series A
Japan, United States, Singapore

Portfolio highlights

Ababa — Ababa provides recruitment and employment solutions.
SALOWIN — SALOWIN is a shared salon where freelance hairdressers can freely provide customer service and service.
Penetrator — Penetrator transforms the real estate market with space technology, tackling transaction issues and forming landslide observation systems.

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.

Investment focus

Manufacturing, Health Care, Software
Series A, Series B, Angel
China, Hong Kong, United States

Portfolio highlights

Pure Water No.1 — Pure Water No.1 is a high-tech enterprise specializing in the design, manufacturing, installation, marketing, operation and service of pure water, ultrapure water, recycled water reuse, sewage treatment, waste gas treatment and seawater desalination systems.
Bandu Technology — Bandu Technology developed immersive 3D light field displays that use AI and big data to transform human connectivity and engagement. It focuses on the intelligent presentation and management of images and data, enabling industrial evolution, creating unlimited industrial space, and creating a new experience for human life.
Damo Intelligent Control — Damo Intelligent Control is a national specialized "little giant" enterprise and a national high-tech enterprise focusing on the research and development, production, sales, and service integration of drone cluster automation performance systems. It is the world's leading supplier of drone cluster automation performance systems.

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Kenya

Portfolio highlights

AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
Kunwei Technology — Kunwei Technology manufactures high-precision force sensors (six-axis force sensors) as well as force control systems. It is involved in the research and development, manufacturing, sales, and technological promotion of intelligent force sensors, as well as the development of force sensor products for the robot and other intelligent equipmentindustries. It provides force measurement systems as well as goods connected to measurement and other industries.
New Vision Medical — New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.

Goldport Capital is a Shenzhen-based asset management company.

Investment focus

Manufacturing, Medical, Semiconductor
Series A, Seed, Series B
China

Portfolio highlights

Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
Chaoguang Micro — Chaoguang Micro specializes in the innovative development of optical products for medical and industrial purposes.
Teyan Semiconductor — Taiyan Semiconductor is a semiconductor process and equipment service provider in the field of advanced packaging. It provides customers with advanced packaging production lines such as SiP, Fanout, Chiplet, 3D, etc. Laser (laser) + Plasma (plasma) + Sputter (coating) complete composite process and Process application equipment.

ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.

Investment focus

Software, Health Care, Information Technology
Seed, Funding Round, Series A
Japan, United States, India

Portfolio highlights

AirX — AirX is a management service company specializing in air transportation agency business and travel arrangement business. The company leverages technology to transform the notion of mobility into an unprecedented experience. It also provides services such as CodeShare, AIROS Skyview, and AIROS Air Loss. AirX will create the movement of the futuresociety, sightseeing and the way of life of helicopter, Empty MaaS, Flying taxi, eVTOL, and Next-generation traffic.AirX was established on February 23, 2015, and is based in Shinjuku-ku, Tokyo, Japan.
Pleap — Pleap is a medical engineering company specializing in the development of AI and IoT-based technology solutions tailored for medical institutions. The company's product offerings include "medimo" which is an AI tool that automatically creates medical record manuscripts from medical audio.
Ryulog — Ryulog is a recruiting company that helps job seekers find international work opportunities and migrate abroad.

Lenovo Capital and Incubator Group is an accelerator and venture capital firm.

Investment focus

Software, Artificial Intelligence, Manufacturing
Series A, Series B, Seed
China, Hong Kong, United States

Portfolio highlights

Lingbao CASBOT — Lingbao CASBOT adheres to the people-oriented development concept, strives to be close to people's real needs in every technological breakthrough, and realize the harmonious coexistence of technology and humanity.
Daimon Robotics — Daimon Robotics is a robotics company that specializes in the development and production of commercially viable general-purpose humanoid robot products with innovative intelligence.
Taifang Technology — ## Build Setup

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Investment focus

Manufacturing, Biotechnology, Health Care
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
Mingxin Digital — Mingxin Digital is a financial technology company dedicated to driving industrial credit management with digital technology.
Zhongtiansheng New Materials — Zhongtiansheng New Materials is a polyimide monomer and resin production company. It also manufactures resin material composites and liquid crystal orientation agents.

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, Singapore, United States

Portfolio highlights

Weimai — Weimai is a developer of a health application platform intended to provide medical and health services. The company's health application platform offers an Internet-based appointment, distribution, maternal and child disease management, grading diagnosis and treatment as well as remote diagnosis, and medical records management, providing userswith a family doctor application in every home.
Haofeng Medtech — Haofeng Medtech is a CDMO service provider of interventional medical devices.
Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.

Investors of Gaorong Capital include world-class sovereign wealth funds, university endowment funds, family foundations, pension funds and fund of funds, as well as successful entrepreneurs, including founders and managements of Tencent, Alibaba, Baidu, JD, Xiaomi, Focus Media and VIPShop. They will provide with valuable industry resources,entrepreneurial experience, and global perspectives.

Investment focus

Information Technology, Artificial Intelligence, Software
Series A, Series B, Seed
China, United States, Hong Kong

Portfolio highlights

Ideaflow — Ideaflow is an AGI-era content technology firm focused on developing a new generation of content platforms powered by multimodal artificial intelligence. Its offering, the Dream Dimension app, is an interactive content platform that features a variety of stunning AI sceneries.
Xinyanyi Code — Xinyanyi Code is an artificial intelligence programming application service provider that focuses on AI Coding and benchmarks the American intelligent code generation product Cursor.
Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Germany

Portfolio highlights

Amazinc — Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.
ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Seed
China, United States

Portfolio highlights

Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.

Taiyu Investment is an investment firm.

Investment focus

Medical, Medical Device, Biotechnology
Series A, Angel, Seed
China

Portfolio highlights

NeuroPlus — NeuroPlus is a developer of bioelectric sensing technologies, with an emphasis on new applications such as precise EEG measurement, smart wearables, and mobile medical care.
Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.

UntroD Capital is an R&D-based innovative technology that specializes in social implementation.

Investment focus

Manufacturing, Biotechnology, Robotics
Funding Round, Seed, Series A
Japan, Singapore, India

Portfolio highlights

Revorf — Revorf analyzes data and develops AI-related to infectious diseases and healthcare.
Mjolnir Spaceworks — Mjolnir Spaceworks desings and manufactures state-of-the-art novel space rockets with efficient engines as well as other space equipments.
Optieum Biotechnologies — Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate tooptimize the immune-cell function for oncology targets.We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need.

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Investment focus

Health Care, Internet, Medical
Funding Round, Seed, Series A
Japan, United States, Ethiopia

Portfolio highlights

AirX — AirX is a management service company specializing in air transportation agency business and travel arrangement business. The company leverages technology to transform the notion of mobility into an unprecedented experience. It also provides services such as CodeShare, AIROS Skyview, and AIROS Air Loss. AirX will create the movement of the futuresociety, sightseeing and the way of life of helicopter, Empty MaaS, Flying taxi, eVTOL, and Next-generation traffic.AirX was established on February 23, 2015, and is based in Shinjuku-ku, Tokyo, Japan.
HQ — HQ offers next-generation employee benefits platform.
Doctor's Prime — Doctor's Prime is a technology company that provides is a part-time job information service for optimizing the working style of doctors.

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
China, United States, Singapore

Portfolio highlights

dinii — Dinii is a mobile order platform for take-out shops.
Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.

Trustbridge Partners is a mission-driven growth equity firm founded in 2006 with approximately $8 billion under management.

Investment focus

Health Care, Education, Medical
Series A, Series B, Series C
China, United States, United Kingdom

Portfolio highlights

Cherre — Connect all your real estate data and make it available to the entire organization for better investment, management, and underwriting decisions.
Hystar — Hystar develops polymer electrolyte membrane electrolyzers designed for large-scale green hydrogen production. Founded in 2020, Hystar's technology uses a unique cell design and process architecture that provides the ability to reduce electricity consumption and increase hydrogen output, enabling professionals to tackle various criticalenergy challenges and having the potential to reduce greenhouse gas emissions.
Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China

Portfolio highlights

JH Cispoly — JH Cispoly develops diagnostic technology and equipment for gynecological tumors.
Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
Medtech Technology — Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.

Tiantu Capital is a venture capital association.

Investment focus

Food and Beverage, E-Commerce, Health Care
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Recorna Bio — Recorna Bio specializes in biotechnology, focusing on RNA editing and genome modifications through advanced research and development. They aim to innovate in genetic engineering, contributing to advancements in biomedicine and agriculture with cutting-edge technologies and scientific expertise.
Leman Biotech — Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies.
Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

LYFE Capital is a pure play healthcare focused investment firm. We believe that “Healthcare has no boundaries”, and that every new choice we made has the potential to advance healthcare and solve the unmet needs for everyone. LYFE Capital operates 5 global offices including our US headquarters in Menlo Park, California, our Asia headquarters inSingapore, as well as locations in Seoul, Tokyo and Shanghai. We leverage our expertise and global resources to invest in and create value for healthcare companies across the globe. LYFE Capital’s investments span medical devices, therapeutics, diagnostics, and emerging sectors across North America and Asia.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
China, United States, France

Portfolio highlights

CytoTronics — Visualize live cell function at scale for cell biology discovery with Pixel systems. Monitor cell viability, morphology, electrophysiology, metabolism and more.
Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
Precision BioSciences — Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS.Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editingtechnology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.

Insight Capital is a venture capital firm focused on early-stage investment.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Series C
China

Portfolio highlights

Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
Amity Solutions — Enterprise Chatbots, AI-based generative Chatbots, pre-built social features for apps and websites, and building blocks for employee experiences.
Iongen Therepeutics — Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment.

Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen. Founded more than 16 years ago, Co-Stone is one of China's earliest private equity institutions. Co-Stone Capital focuses primarily on China domestic growth stage and Pre-IPO opportunities, basing investment decisions on a deep understanding of the Chineseeconomy and company specific growth patterns. We put heavy emphasis on stable growth in key industries, including TMT, healthcare, consumer products & services and advanced manufacturing. Co-Stone Capital approaches the capital markets with broad vision but detailed focus, maintaining an emphasis on value-adding services. We have invested in over 100 companies, the majority of which were lead investments and have successfully exited from 40 companies through IPO, M&A or reverse mergers. Our exit rates and ROI are far in excess of industry averages. Co-Stone Capital has assets under management in excess of 40 billion RMB, across funds covering private equity, venture capital, PIPE, M&A and fixed income. Co-Stone has a diverse capital base, with LPs ranging across large insurance groups, government guided funds, funds of funds, large corporations, entrepreneurs and high net worth individuals. Co-Stone Capital has received numerous accolades from Forbes, Zero2IPO,ChinaVenture and other industry publications which consistently rank us in the top 10. Co-Stone Capital is headquartered in Shenzhen, with offices in Beijing，Shanghai and Hefei.

Investment focus

Manufacturing, Semiconductor, Health Care
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

HONOR — Established in 2013 by Huawei, Honor is a leading global provider of smart devices. We are committed to becoming a global iconic tech brand and enabling a smart life across all scenarios and all channels, for all people. With a strategic focus on innovation, quality and service, honor is dedicated to developing technology that empowers peoplearound the globe to go beyond through its R&D capabilities and forward-looking technology, as well as creating a new intelligent world for everyone with its portfolio of innovative products.
Metrono — Metrono is a manufacturer of cable and optical cable that provides high-performance rail transit special cable solutions and supplies a full range of European standard locomotive cables.
X Square — X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

Investment focus

Manufacturing, Health Care, Information Technology
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Maigang Data — Maigang Data provides digital construction and applications for industry users based on digital technologies such as big data and artificial intelligence.
Juci Technology — Juci Technology specializes in the production of aluminum nitride powder and ceramic products.
Accro Bioscience — Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.

Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.

Investment focus

Medical, Health Care, Medical Device
Series A, Series B, Angel
China, United States

Portfolio highlights

Filan Air — Filan Air develops technology for improving air quality, such as air treatment for medical laboratories.
Aibo Medical Robot — Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
Oushisheng Technology — Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world.

Established in 2000, SB China Capital (SBCVC) is a leading venture capital and private equity firm that manages both USD and RMB funds. Their investment focuses on high-tech, high growth companies in TMT, clean technology, healthcare, consumer/retail, and advanced manufacturing sectors; and they invest across all stages of companies.Withextensive entrepreneurial and operating experiences, their professional and seasoned deal team members recognize the vision and champion the ideas of start-up companies. In addition to providing capital support, they help their portfolio companies realize their strategic and commercial potential by giving value-adding services and advices including planning, business development, recruiting and resources deployment.They have a proven track record and solid reputation in identifying high potential start-ups and creating successful industry-leading companies. Some of their spotlight portfolio companies are Alibaba, Taobao, Focus Media, GDS, BGI, Ankon, Di’an, and Edan.With their operational headquarters located in Shanghai and regional offices spread in Beijing, Shenzhen, Chengdu, Hangzhou and Taiwan, they have an extensive coverage of the greater China region and access to potential investment opportunities.

Investment focus

Health Care, Software, Information Technology
Series A, Series B, Series C
China, United States, Australia

Portfolio highlights

UCaize — UCaize is a biopharmaceutical company that researches and develops novel medications for the treatment of blood cancers.
Shengyin Optoelectronics — Shengyin Optoelectronics is a platform-based micro-nano manufacturing firm that creates ornamental films for electrical appliances and portable electronics.
Xindi Digital Engineering System — Xindi Digital Engineering System specializes in the development of 3D CAD software for manufacturing enterprises.

Taiyu Investment is an investment firm.

Investment focus

Medical, Health Care, Biotechnology
Series A, Seed, Angel
China

Portfolio highlights

Immorna — Immorna specializes in the production of RNA-based therapeutics.
ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.

BIOCHING CAPITAL is an investment management firm.

Investment focus

Medical Device, Biotechnology, Medical
Angel, Series A, Seed
China

Portfolio highlights

Taose Tuantuan — Taose Tuantua is a sex toy company that primarily offers TAOSETT sex toy academy and exquisite sex toy community store services.
Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
Qinglan Jichuang — Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Software, Manufacturing, Information Technology
Series A, Series B, Seed
China, United States

Portfolio highlights

Aiator — Aiator is an artificial intelligence product and technology solutions company focusing on industrial fields and biotechnology. Founded in 2010 by Silicon Valley Artificial Intelligence Scientist in Shenzhen Qianhai DreamWorks, the core members of the team are from the United States, the United Kingdom, Australia and Hong Kong. Currently, there arefour peacock talents and nearly 30 independent intellectual property rights. Weiai Intelligent is committed to carrying out AI empowerment services for enterprises, reducing costs and increasing efficiency.
Mufan Power — Mufan Power is a new energy high-tech enterprise in the field of turbomachinery. It is committed to the development of a new generation of zero-carbon hydrogen power generation technologies and products. Its main products are hydrogen gas turbines, which can be used in distributed energy and data centers. , rail transit, ship power, vehicle power,energy storage peak shaving and other carbon neutral scenarios.
Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT